Company news
Repligen Corporation (NASDAQ:RGEN) news
Repligen Corporation news releases on 6ix. Latest, Oct 6, 2026: Repligen Completes Acquisition of BioLife Solutions
Press releases & updates
Repligen Completes Acquisition of BioLife Solutions
October 6, 2026
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
August 26, 2026
Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
July 28, 2026
Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media
July 22, 2026
Repligen to Report Second Quarter 2026 Financial Results
July 15, 2026
Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference
May 22, 2026
Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report
May 20, 2026
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference
May 7, 2026
Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
May 5, 2026
Repligen to Report First Quarter 2026 Financial Results
April 22, 2026
908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 21, 2026
Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network
April 17, 2026
Repligen Corporation to Present at Upcoming March Conferences
March 4, 2026
Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
February 24, 2026
Repligen to Report Fourth Quarter and Full Year 2025 Financial Results
February 10, 2026
Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair
January 6, 2026
Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference
December 17, 2025
Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows
December 15, 2025
Repligen Corporation to Present at Evercore Healthcare Conference
November 25, 2025
Repligen Corporation to Present at Upcoming November Conferences
November 3, 2025
Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
October 27, 2025
Repligen to Report Third Quarter 2025 Financial Results
October 14, 2025
Repligen Corporation to Present at Upcoming September Conferences
August 21, 2025
Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization
July 30, 2025
Repligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
July 28, 2025
Repligen to Report Second Quarter 2025 Financial Results
July 16, 2025
908 Devices Appoints Christopher D. Brown to its Board of Directors
June 15, 2025
Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report
May 26, 2025
Repligen Corporation to Present at William Blair Growth Conference
May 21, 2025
Repligen Corporation to Present at Upcoming May Investor Conferences
May 6, 2025
Repligen Reports First Quarter 2025 Financial Results
April 28, 2025
Repligen to Report First Quarter 2025 Financial Results
April 14, 2025
Repligen Appoints Jacob Johnson As Vice President Investor Relations
April 7, 2025
Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
March 3, 2025
Repligen Reports Fourth Quarter and Full Year 2024 Financial Results
February 19, 2025
Repligen to Report Fourth Quarter and Full Year 2024 Financial Results
February 10, 2025
Repligen Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 6, 2025
Repligen Launches the CTech™ SoloVPE® PLUS System
January 5, 2025
Repligen Announces Publication of the Company’s 2023 Corporate Sustainability Report
December 11, 2024
Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns
December 8, 2024
Repligen Reports Third Quarter 2024 Financial Results
November 11, 2024
Repligen Corporation to Present at Upcoming Investor Conferences
November 4, 2024
Repligen to Report Third Quarter 2024 Financial Results
October 30, 2024
Repligen Opens Training & Innovation Center to Elevate Customer Experience
September 23, 2024
Repligen Corporation to Present at Wells Fargo Healthcare Conference
August 22, 2024
Repligen Reports Second Quarter 2024 Financial Results
July 29, 2024
Repligen Announces Agreement to Acquire Chromatography Innovator Tantti
July 28, 2024
Repligen to Report Second Quarter 2024 Financial Results
July 15, 2024
Repligen Announces CEO Transition Plan
June 12, 2024
Ecolab Life Sciences and Repligen Announce the Commercial Launch of DurA Cycle Affinity Resin for Large-Scale Biologic Manufacturing
June 2, 2024